Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
11.33%
↑ 108% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthAccelerating
Average
-148.21%
Historical baseline
PeriodValue
202511.33%
2024-127.27%
2023-168.93%
2022-68.11%
2021-536.26%
20200.00%